| Literature DB >> 26379776 |
Shao Thing Teoh1, Sastia Putri1, Yukio Mukai2, Takeshi Bamba1, Eiichiro Fukusaki1.
Abstract
BACKGROUND: Traditional approaches to phenotype improvement include rational selection of genes for modification, and probability-driven processes such as laboratory evolution or random mutagenesis. A promising middle-ground approach is semi-rational engineering, where genetic modification targets are inferred from system-wide comparison of strains. Here, we have applied a metabolomics-based, semi-rational strategy of phenotype improvement to 1-butanol tolerance in Saccharomyces cerevisiae.Entities:
Keywords: 1-Butanol tolerance; Metabolomics; Orthogonal projections to latent structures; Phenotype improvement; Regression model; Saccharomyces cerevisiae; Semi-rational strain engineering
Year: 2015 PMID: 26379776 PMCID: PMC4570087 DOI: 10.1186/s13068-015-0330-z
Source DB: PubMed Journal: Biotechnol Biofuels ISSN: 1754-6834 Impact factor: 6.040
Rational, semi-rational and random approaches in strain engineering
| Rational | Semi-rational | Random |
|---|---|---|
| Gene modifications based on knowledge of genetic mechanisms and metabolic pathways governing the phenotype | Genetic modifications based on system-level comparison between strains, conditions, etc. | Genetic changes driven by random processes |
| Ex. Expression of heat-shock proteins or alcohol efflux pumps for heat or alcohol stress tolerance, respectively | Ex. Genome-wide or transcriptome-wide comparison | Ex. Laboratory evolution, induced transcription factor mutagenesis |
| Dependence on availability of prior knowledge | Not limited by lack of prior knowledge | Not limited by lack of prior knowledge |
| Results contribute additional information on relevant or important genes | Results contribute additional information on relevant or important genes | Results by themselves do not provide information on which genes are relevant/important |
| Elucidation of mechanisms is complicated and time-consuming | High-throughput, comprehensive ‘omics’ analytical technology is required | Screening step often required to recover the improved strains |
Fig. 1Metabolomics-based strategy of phenotype improvement. Various mutant strains of S. cerevisiae are cultivated in the presence of 1-butanol stress to measure their tolerances. These strains are also cultivated under the non-stress condition for metabolome analysis. The metabolomics and tolerance data are combined to construct a regression model, which provides information on which metabolites are strongly associated with tolerance. On the assumption that these metabolites have a causal relationship with tolerance, the corresponding metabolic pathways are examined, and gene deletion targets predicted to modify metabolite pools in the direction associated with increased tolerance are then identified. Finally, new deletion strains are obtained, and their tolerances and metabolite pools are measured to validate the model predictions
Strains selected for metabolome analysis and regression modeling
| Strain | Description in |
|---|---|
|
| Zinc-finger transcriptional activator of the Zn2Cys6 family; activates transcription of aromatic amino acid catabolic genes in the presence of aromatic amino acids |
|
| Zinc-finger transcription factor, involved in induction of CLN3 transcription in response to glucose; genetic and physical interactions indicate a possible role in mitochondrial transcription or genome maintenance |
|
| Myb-related transcription factor involved in regulating basal and induced expression of genes of the purine and histidine biosynthesis pathways; also involved in regulation of meiotic recombination at specific genes |
|
| Negative regulator of genes in multiple nitrogen degradation pathways; expression is regulated by nitrogen levels and by Gln3p; member of the GATA-binding family, forms homodimers and heterodimers with Deh1p |
|
| Protein containing GATA family zinc-finger motifs; similar to Gln3p and Dal80p; expression repressed by leucine |
|
| Basic leucine zipper (bZIP) transcriptional activator of amino acid biosynthetic genes in response to amino acid starvation; expression is tightly regulated at both the transcriptional and translational levels |
|
| Zinc-knuckle transcription factor, repressor and activator; regulates genes involved in branched chain amino acid biosynthesis and ammonia assimilation; acts as a repressor in leucine-replete conditions and as an activator in the presence of alpha-isopropylmalate, an intermediate in leucine biosynthesis that accumulates during leucine starvation |
|
| Transcriptional activator involved in regulation of genes of the lysine biosynthesis pathway; requires 2-aminoadipate semialdehyde as co-inducer |
|
| Pleiotropic negative transcriptional regulator involved in Ras-CAMP and lysine biosynthetic pathways and nitrogen regulation; involved in retrograde (RTG) mitochondria-to-nucleus signaling |
|
| Transcriptional repressor and activator with two C2-H2 zinc fingers; involved in repression of a subset of hypoxic genes by Rox1p, repression of several DAN/TIR genes during aerobic growth, and repression of ergosterol biosynthetic genes in response to hyperosmotic stress; contributes to recruitment of the Tup1p-Cyc8p general repressor to promoters; involved in positive transcriptional regulation of CWP2 and other genes; can form the [MOT3+] prion |
|
| Oleate-activated transcription factor, acts alone and as a heterodimer with Pip2p; activates genes involved in beta-oxidation of fatty acids and peroxisome organization and biogenesis |
|
| Transcriptional activator of proline utilization genes, constitutively binds PUT1 and PUT2 promoter sequences as a dimer and undergoes a conformational change to form the active state; differentially phosphorylated in the presence of different nitrogen sources; has a Zn(2)-Cys(6) binuclear cluster domain |
|
| Zinc-finger protein involved in transcriptional control of both nuclear and mitochondrial genes, many of which specify products required for glycerol-based growth, respiration, and other functions |
|
| C6 zinc cluster transcriptional activator that binds to the carbon source-responsive element (CSRE) of gluconeogenic genes; involved in the positive regulation of gluconeogenesis; regulated by Snf1p protein kinase; localized to the nucleus |
|
| Basic leucine zipper transcription factor of the ATF/CREB family; forms a complex with Tup1p and Cyc8p to both activate and repress transcription; cytosolic and nuclear protein involved in osmotic and oxidative stress responses |
|
| Transcription factor, activated by proteolytic processing in response to signals from the SPS sensor system for external amino acids; activates transcription of amino acid permease genes |
|
| Transcriptional activator of thiamine biosynthetic genes; interacts with regulatory factor Thi3p to control expression of thiamine biosynthetic genes with respect to thiamine availability; acts together with Pdc2p to respond to thiaminediphosphate demand, possibly as related to carbon source availability; zinc-finger protein of the Zn(II)2Cys6 type |
|
| Serine-rich protein that contains a basic-helix-loop-helix (bHLH) DNA binding motif; binds E-boxes of glycolytic genes and contributes to their activation; may function as a transcriptional activator in Ty1-mediated gene expression |
|
| Basic leucine zipper (bZIP) transcription factor; physically interacts with the Tup1-Cyc8 complex and recruits Tup1p to its targets; overexpression increases sodium and lithium tolerance; computational analysis suggests a role in regulation of expression of genes involved in carbohydrate metabolism |
Fig. 21-Butanol tolerance measurements for 19 selected strains. Specific growth rates for selected strains under 1.5 % (v/v) 1-butanol stress condition (µ stress). The BY4742 parental strain is also included for reference. Columns represent average values and error bars represent standard deviations from duplicate measurements. The measurement values are found in Additional file 1: Table S3
Metabolites identified by GC/MS
| Amino acids, intermediates and derivatives | ||
| Alanine | Glycine | Serine |
| Asparagine | Isoleucine | Threonine |
| Aspartic acid | Leucine | Tryptophan |
| Cystathionine | Lysine | Tyrosine |
| Cystine | Phenylalanine | Valine |
| Glutamic acid | Proline | |
| Glutamine | Pyroglutamic acid | |
| Glycolysis and TCA cycle compounds | ||
| Isocitric acid/citric acid | Malic acid | Oxalacetic acid/pyruvic acid |
| Nucleic acids and intermediates | ||
| Orotic acid | Uracil | |
| Urea cycle compounds | ||
| Ornithine | Urea | |
| Polyamines | ||
| Cadaverine | Spermidine | |
| Others | ||
| 2-Aminoadipic acid | Lactic acid | Plamitic acid (16:0) |
| 4-Aminobenzoic acid |
| Quinolinic acid |
| Glucarate | Phthalic acid | Stearic acid (17:0) |
Two compounds separated by a slash (/) indicates that the compounds could not be differentiated by our analytical method. For more information see also Additional file 1: Table S5
Fig. 3OPLS model observed vs predicted plot. Response variable (tolerance) values calculated from metabolite data of each sample according to the model (µ stress_Predicted), plotted against the corresponding strain’s average measured tolerance (µ stress_Observed). N = 4 samples were prepared for each strain in the metabolome analysis
Fig. 4Metabolite scores according to the OPLS model. a VIP scores. b Coefficients. See text for a detailed explanation of these scores. The error bars in the VIP and coefficient plots represent standard error estimated from cross-validation
Potential 1-butanol tolerance-related metabolites identified from the OPLS model
| Metabolite | High VIP | Large coeff | Correlation |
|---|---|---|---|
| 2-Aminoadipic acid | ✔ | Positive | |
|
| ✔ |
| |
| Cadavarine | ✔ | Negative | |
| Cystathionine | ✔ | Negative | |
|
| ✔ | ✔ |
|
|
| ✔ |
| |
|
| ✔ |
| |
|
| ✔ | ✔ |
|
| Valine | ✔ | Negative |
Italics indicates that the metabolite was subsequently considered for validation using metabolic enzyme deletion mutant(s)
Fig. 5Metabolic pathways and genes related to threonine biosynthesis and the TCA cycle. Metabolites marked in bold blue (threonine, aspartate) were positively correlated with tolerance, while metabolites marked in bold red (citrate, glutamate, glutamine) were negatively correlated with tolerance
New strains selected according to important metabolites in the model
| Strain | Enzyme encoded by gene | Rationale for selection |
|---|---|---|
|
|
| Reducing threonine conversion into 2-oxobutanoate may increase threonine accumulation |
|
|
| Preventing carbon flow from homoserine into methionine biosynthesis may increase threonine production |
|
| Citrate synthase | Reducing acetyl-CoA and oxaloacetate condensation may decrease citrate level and/or TCA cycle activity |
|
| Citrate synthase | Reducing acetyl-CoA and oxaloacetate condensation may decrease citrate level and/or TCA cycle activity |
|
| Citrate synthase | Reducing acetyl-CoA and oxaloacetate condensation may decrease citrate level and/or TCA cycle activity |
|
| Aspartate aminotransferase | Reducing transamination of oxaloacetate and glutamate to aspartate and α-ketoglutarate may decrease threonine production and increase glutamate accumulation |
|
| Aspartate aminotransferase | Reducing transamination of oxaloacetate and glutamate to aspartate and α-ketoglutarate may decrease threonine production and increase glutamate accumulation |
Fig. 6Experimental results for new strains selected based on model. Specific growth rates, under 1.5 % (v/v) 1-butanol stress condition, for new strains selected based on the model. Columns represent average values and error bars represent standard deviations from at least 3 replicate measurements. The measurement values are found in Additional file 1: Table S6
Fig. 7Experimental results for new strains selected based on model. a Relative threonine levels for cha1∆, met2∆, and his3∆ (control strain). Columns represent average values from n = 4 samples. b Relative citrate levels for cit1-3∆, aat1-2∆, and his3∆. Columns represent average values from n = 4 samples